At the top, two aliphatic glucosinolates are shown: sinigrin (2-propenylglucosinolate) and glucoraphanin (4-methylsulfinylbutylglucosinolate)
For patients whove been turned away from fertility care based on their BMI, these drugs may put treatment within reach again
Most people in normal weight ranges use standard doses successfully
Adults using semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% with placebo
Because volunteer 2 had Body Mass Index (BMI) below the lower limit (18.5) of the normal range (only 16.86), his lipid stores may not have been sufficient, so that his supplies of 2- and 3-HB were also lower than normal (Fig
*Correspondence: Ken Takahashi [email protected] This article was submitted to Cardiovascular Metabolism, a section of the journal Frontiers in Cardiovascular Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
